ArticleScientific reports2025
In vitro effects of potato glycoalkaloids on plant-pathogens, beneficial microbes, and Arabidopsis thaliana.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Activity ofToxins · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Potato glycoalkaloids (PGAs), α-solanine and α-chaconine, are secondary metabolites related to plant defense. Highly concentrated in the upper part of potato plants, they exhibit antimicrobial properties. Seeking more sustainable crop protection strategies, this study investigates the effects of PGAs on plant pathogens and beneficial organisms. These organisms were exposed to different PGA concentrations (0.98 to 250 ppm), with evaluations focusing on developmental and survival metrics. Key findings highlight α-chaconine as the more potent compound, causing significantly stronger adverse effects across tested organisms. E.g., α-chaconine (≤ 25 ppm) reduced nematode mobility by 43%, host attraction by > 45%, and infection rates by 63%. At 250 ppm, α-solanine moderately reduced mycelial growth, while α-chaconine reduced it by 78%. Crucially, beneficial organisms experienced minimal growth impairment (≤ 19%) even at the highest concentration (250 ppm). Arabidopsis thaliana seedling development was impaired by both PGAs, and seedlings exposed to these compounds exhibited a strong, transient oxidative burst, indicating direct stress activation. Pretreatment with PGAs did not induce priming effects but even decreased subsequent elicitor-induced responses. The selective toxicity against pathogens, coupled with minimal impact on beneficial species, positions PGAs, particularly α-chaconine, as promising starting points for sustainable crop protection strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.